Condition

Ductal Carcinoma in Situ clinical trials and research

• 10Clinical trials
• 1NIH research projects
• 3Countries

Newest Ductal Carcinoma in Situ clinical trials

All recruiting trials (10)

• How social factors relate to inflammation in women with breast cancer.

  This pilot will try to link social and economic factors to blood markers of inflammation in women newly diagnosed with breast cancer who have not yet started treatment.

  Recruiting Thomas Jefferson University · Philadelphia, Pennsylvania · NCT07478016

• CAN1012 injection before surgery for DCIS or LCIS

  A phase 1 study tests CAN1012 injected into the lesion of patients with DCIS or LCIS to see if it is safe before they have planned surgery.

  Recruiting Phase 1 Providence Health & Services · Portland, Oregon · NCT07408856

• Disappearing markers for daily breast radiation delivery

  This trial will test whether Magic Ink tattoos are as safe and remain visible as standard tattoo ink for women getting radiation after breast cancer surgery.

  Recruiting Barbara Ann Karmanos Cancer Institute · Detroit, Michigan · NCT07095114

• Cavity marking technique to improve radiotherapy planning after breast-conserving oncoplastic surgery

  This will test a new cavity-marking method to help radiation teams plan treatment more accurately for adults having breast-conserving surgery with oncoplastic reconstruction.

  Recruiting University of Florida · Gainesville, Florida · NCT06903468

• Radiation therapy for early-stage breast cancer using a shorter treatment schedule

  This study is testing a shorter radiation treatment schedule for women 50 and older with early-stage breast cancer to see if it is safe and effective while reducing the number of visits needed.

  Recruiting Phase 2 UNC Lineberger Comprehensive Cancer Center · Chapel Hill, North Carolina · NCT06902311

• Preoperative partial breast irradiation for early-stage breast cancer

  This study is testing if giving radiation therapy before surgery for early-stage breast cancer can lead to fewer side effects compared to the usual treatment given after surgery.

  Recruiting Phase 2 Yonsei University · Seoul · NCT06677944

• Vaccine targeting MUC1 to prevent ductal carcinoma in situ progression

  This study is testing whether a new vaccine can help post-menopausal women with ductal carcinoma in situ prevent it from progressing to invasive breast cancer when combined with a common treatment.

  Recruiting Phase 1 University of Pittsburgh · Pittsburgh, Pennsylvania · NCT06218303

• Evaluating active surveillance and hormonal therapy for early-stage breast cancer

  This study is testing if a combination of careful monitoring and hormonal treatment can help women with early-stage breast cancer avoid surgery while keeping an eye on their condition.

  Recruiting at 27 sites Phase 2 QuantumLeap Healthcare Collaborative · Berkeley, California and 29 other locations · NCT06075953

• Accelerated Partial Breast Irradiation using Stereotactic Body Radiation Therapy

  This study is testing a new type of targeted radiation treatment for women with certain types of breast cancer to see if it is safe and effective.

  Recruiting at 2 sites RPCR, Inc. · Stuart, Florida and 1 other locations · NCT04985032

• Neoadjuvant hormone therapy for extensive ductal carcinoma in situ

  This study is testing if giving hormone therapy before surgery can help women with extensive ductal carcinoma in situ avoid a mastectomy and have better treatment outcomes.

  Recruiting at 7 sites Phase 2 Institut Cancerologie de l'Ouest · Angers and 7 other locations · NCT04666961

NIH-funded research (1)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• Identifying markers to predict which ductal carcinoma in situ may become invasive

  This study is looking at a type of non-invasive breast cancer called DCIS to find clues that can help doctors know which cases might turn into more serious cancer, so they can create better, more personalized treatment plans for patients.

  NIH research Flanders Interuniv Inst Biotechnology · Gent, Belgium · NIH-11067856

Related topics

Quick answers

How many Ductal Carcinoma in Situ clinical trials are recruiting right now?

10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in United States (8 trials), South Korea (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 4, Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →